These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 443884)

  • 1. Acetylator phenotype in spontaneous SLE and rheumatoid arthritis.
    Lawson DH; Henry DA; Lowe J; Reavey P; Rennie JA; Solomon A
    Ann Rheum Dis; 1979 Apr; 38(2):171-3. PubMed ID: 443884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug acetylation and expression of lupus erythematosus.
    Marsden JR; Mason GG; Coburn PR; Rawlins MD; Shuster S
    Eur J Clin Pharmacol; 1985; 28(4):387-90. PubMed ID: 4029245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylator phenotype in systemic lupus erythematosus.
    Foad B; Litwin A; Zimmer H; Hess EV
    Arthritis Rheum; 1977 Apr; 20(3):815-8. PubMed ID: 301027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphic acetylator phenotype and systemic lupus erythematosus.
    Johansson E; Mustakallio KK; Mattila MJ
    Acta Med Scand; 1981; 210(3):193-6. PubMed ID: 6974957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylator polymorphism in rheumatoid arthritis.
    Ladero JM; Andres MP; Bañares A; Fernández B; Hernández C; Benítez J
    Eur J Clin Pharmacol; 1993; 45(3):279-81. PubMed ID: 8276055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylator phenotype and metabolic disposition of isoniazid in Japanese patients with systemic lupus erythematosus.
    Ishizaki T; Horai Y; Koya G; Matsuyama K; Iguchi S
    Arthritis Rheum; 1981 Oct; 24(10):1245-54. PubMed ID: 7306226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal distribution of acetylation phenotypes in systemic lupus erythematosus.
    Vansant J; Woosley RL; John JT; Sergent JS
    Arthritis Rheum; 1978 Mar; 21(2):192-5. PubMed ID: 637885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylator phenotype in idiopathic systemic lupus erythematosus.
    Reidenberg MM; Levy M; Drayer DE; Zylber-Katz E; Robbins WC
    Arthritis Rheum; 1980 May; 23(5):569-73. PubMed ID: 7378086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug acetylation phenotype unrelated to development of spontaneous systemic lupus erythematosus.
    Morris RJ; Freed CR; Kohler PF
    Arthritis Rheum; 1979 Jul; 22(7):777-80. PubMed ID: 454504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further evidence for the lack of association between acetylator phenotype and systemic lupus erythematosus.
    Baer AN; Woosley RL; Pincus T
    Arthritis Rheum; 1986 Apr; 29(4):508-14. PubMed ID: 3707628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylator phenotype in Iraqi patients with systemic lupus erythematosus.
    Najim RA; Farid YY; Samad TA; Shihab SA
    East Mediterr Health J; 2005; 11(5-6):1003-8. PubMed ID: 16761671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.
    Horai Y; Ishizaki T; Sasaki T; Koya G; Matsuyama K; Iguchi S
    Br J Clin Pharmacol; 1982 Mar; 13(3):361-74. PubMed ID: 7059436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acetylation phenotype in systemic lupus erythematosus].
    Orłowska-Westwood B; Skretkowicz J; Orszulak D; Krykowski E; Mazurowa A
    Pol Arch Med Wewn; 1980 Nov; 64(5):431-4. PubMed ID: 7220361
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis.
    Pullar T; Hunter JA; Capell HA
    Ann Rheum Dis; 1985 Dec; 44(12):831-7. PubMed ID: 2867746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between slow acetylator status and spontaneous lupus erythematosus.
    Kumana CR; Chan MM; Wong KL; Wong RW; Kou M; Lauder IJ
    Clin Pharmacol Ther; 1990 Aug; 48(2):208-13. PubMed ID: 2379389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylator phenotype and lupus erythematosus.
    Uetrecht JP; Woosley RL
    Clin Pharmacokinet; 1981; 6(2):118-34. PubMed ID: 7011656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinuclear antibodies related to acetylator phenotype in mice.
    Tannen RH; Weber WW
    J Pharmacol Exp Ther; 1980 Jun; 213(3):485-90. PubMed ID: 6970809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between serum isonicotinic acid hydrazide (INH) levels and urinary sulfadimidine (sulfamethazine) acetylation as predictors of INH acetylator status.
    Seth V; Seth SD; Beotra A; Singh U
    Dev Pharmacol Ther; 1988; 11(1):32-6. PubMed ID: 3383719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylator phenotype and congenital malformations.
    Stoll C; Roth MP; Dott B; Doumit N; Alembik Y; Welsch M; Imbs JL
    Eur J Clin Pharmacol; 1989; 36(2):151-3. PubMed ID: 2721540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of the human acetylator polymorphism in spontaneous disorders.
    Evans DA
    J Med Genet; 1984 Aug; 21(4):243-53. PubMed ID: 6387123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.